Clinical Trial: A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07783854) titled 'A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity' on Aug. 19.

Brief Summary: The goal of this clinical trial is to determine whether a semaglutide dose-tapering regimen is non-inferior to a treatment-dose maintenance regimen for weight-loss maintenance in adults with overweight or obesity who have achieved stable weight loss. This trial will also evaluate the safety of the dose-tapering regimen.

The primary research questions are:

Is the semaglutide dose-tapering regimen non-inferior to the treatment-dose maintenance regimen for weight-loss maint...